Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Yervoy | ipilimumab | Bristol-Myers Squibb Company | N-125377 RX | 2011-03-25 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
yervoy | Biologic Licensing Application | 2023-02-15 |
Expiration | Code | ||
---|---|---|---|
ipilimumab, Yervoy, Bristol-Myers Squibb Company | |||
2027-10-02 | Orphan excl. |
Code | Description |
---|---|
J9228 | Injection, ipilimumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 105 | 148 | 19 | 2 | 41 | 274 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 22 | 29 | 6 | 1 | 10 | 63 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 10 | 16 | 5 | 1 | 3 | 28 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 2 | 7 | 2 | 1 | 8 | 19 |
Biliary liver cirrhosis | D008105 | — | K74.3 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 64 | 62 | 4 | — | 6 | 105 |
Non-small-cell lung carcinoma | D002289 | — | — | 32 | 48 | 15 | — | 7 | 84 |
Prostatic neoplasms | D011471 | — | C61 | 14 | 23 | 2 | — | — | 37 |
Colorectal neoplasms | D015179 | — | — | 14 | 18 | 4 | — | 1 | 31 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 17 | 16 | 1 | — | — | 28 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 12 | 15 | 1 | — | 1 | 25 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 11 | 11 | 2 | — | — | 21 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 10 | 12 | 3 | — | — | 20 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 8 | 12 | 3 | — | — | 19 |
Glioblastoma | D005909 | EFO_0000515 | — | 8 | 8 | 2 | — | 1 | 17 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Uveal neoplasms | D014604 | EFO_1001230 | — | 13 | 14 | — | — | — | 23 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 9 | 6 | — | — | — | 12 |
Adenocarcinoma | D000230 | — | — | 2 | 8 | — | — | 1 | 11 |
Myelodysplastic syndromes | D009190 | — | D46 | 9 | 2 | — | — | — | 11 |
Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 1 | — | — | — | 11 |
Urologic neoplasms | D014571 | — | C64-C68 | 8 | 5 | — | — | 1 | 11 |
Multiple myeloma | D009101 | — | C90.0 | 7 | 5 | — | — | — | 10 |
Lymphoma | D008223 | — | C85.9 | 9 | 4 | — | — | — | 10 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 4 | 5 | — | — | — | 9 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 8 | 2 | — | — | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 4 | — | — | — | — | 4 |
Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 3 | — | — | — | — | 3 |
Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
Primary myelofibrosis | D055728 | — | D47.4 | 2 | — | — | — | — | 2 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | 1 | 2 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 2 | — | — | — | — | 2 |
T-cell lymphoma peripheral | D016411 | — | — | 2 | — | — | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | — | — | — | — | 2 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
Myeloid leukemia chronic-phase | D015466 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autoimmune diseases | D001327 | HP_0002960 | M30-M36 | — | — | — | — | 3 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 2 | 2 |
Myocarditis | D009205 | — | I51.4 | — | — | — | — | 2 | 2 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
Microbiota | D064307 | — | — | — | — | — | — | 2 | 2 |
Metagenome | D054892 | — | — | — | — | — | — | 2 | 2 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 1 | 1 |
Pericarditis | D010493 | EFO_0007427 | I30 | — | — | — | — | 1 | 1 |
Vasculitis | D014657 | HP_0002633 | — | — | — | — | — | 1 | 1 |
Drug common name | Ipilimumab |
INN | ipilimumab |
Description | Ipilimumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | >7SU0:H,I|Fab heavy chain
(PCA)VQLVESGGGVVQPGRSLRLSCAASGFTFSHYTMHWVRQAPGKGLEWVTFISYDGHNKYYADSVKGRFTISRDNSK
NTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVT
VSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCGGHHHHHH
>7SU0:L,M|Fab light chain
EIVLTQSPGTLSLSPGERATLSCRASQEVGESELAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLE
PEDFAVYYCQQYGSSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNS
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5TRU, 5XJ3, 6JC2, 6RP8, 7SU0, 7SU1 |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1789844 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06186 |
UNII ID | 6T8C155666 (ChemIDplus, GSRS) |